HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.

Brain · 2018 · PMC5837793 · PMID 29415205

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

2 D and F), while quantitative PCR analysis showed a trend towards upregulated GlyRS expression ( Supplementary Fig. 1D ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.